نتایج جستجو برای: levofloxacin

تعداد نتایج: 3327  

2018
Xiaoying Kong Wenhua Xu Cuiping Zhang Wei Kong

In the present study, a temperature-sensitive gel composed of chitosan, carboxymethyl chitosan and glycerophosphate was prepared and loaded with chitosan microspheres encapsulating levofloxacin. The bioavailability of levofloxacin and the safety of this novel opthalmic drug delivery formulation were evaluated. Levofloxacin chitosan microspheres were prepared using the ionic gelation method, and...

2011
Hemant Sahu Vivek Jain Niraj Upmanyu Subhendu S. Mishra Navdeep Raghuwanshi

Levofloxacin effervescent sustained release tablets were developed in eight different formulations (F1 to F8) by employing different grades of polymers and effervescent agents such as sodium bicarbonate and citric acid. The formulations were evaluated for various physical parameters, dissolution parameters and drug released mechanisms. F8 formulation showed maximum floating time of 12 hours and...

Journal: :Antimicrobial agents and chemotherapy 2011
Jyh-Ming Liou Chi-Yang Chang Wang-Huei Sheng Yu-Chi Wang Mei-Jyh Chen Yi-Chia Lee Hsu-Wei Hung Hung Chian San-Chun Chang Ming-Shiang Wu Jaw-Town Lin

The accuracy of genotypic resistance to levofloxacin (gyrA mutations) and its agreement with treatment outcomes after levofloxacin-based therapy have not been reported. We aimed to assess the correlation. Helicobacter pylori strains isolated from patients who received levofloxacin-based and clarithromycin-based triple therapies in a previous randomized trial were analyzed for point mutations in...

Journal: :Chest 2007
Carlton K K Lee Michael P Boyle Marie Diener-West Lois Brass-Ernst Michelle Noschese Pamela L Zeitlin

BACKGROUND Cystic fibrosis (CF) patients have enhanced renal clearance of aminoglycosides and several beta-lactams and require higher dosages. Levofloxacin is a fluoroquinolone with extensive renal elimination and enhanced penetration into lungs and Pseudomonas aeruginosa (PA) biofilms. We studied the preliminary pharmacokinetic and pharmacodynamic (PK/PD) relationship of levofloxacin in CF. ...

2017
Priyanka Sharma Sushila Dahiya Bhavana Kumari Veeraraghavan Balaji Seema Sood Bimal Kumar Das Arti Kapil

BACKGROUND & OBJECTIVES The emergence of resistance to fluoroquinolones in enteric fever despite the pathogen being susceptible by in vitro laboratory results, led to repeated changes in Clinical and Laboratory Standard Institute (CLSI) guidelines for this class of antibiotics to have specific and sensitive interpretative criteria. In 2015, CLSI added pefloxacin disk diffusion criteria as a sur...

2004
Amina Mohamed El-Brashy Mohamed El-Sayed Fawzi Abdallah El-Sepai

Two simple, rapid and sensitive spectrophotometric methods for the determination of three fluoroquinolones, namely levofloxacin, norfloxacin and ciprofloxacin have been performed either in pure form or in their tablets. In the first method, levofloxacin and norfloxacin are directly treated with bromocresol green (BCG) in dichloromethane while ciprofloxacin is allowed to react with the same dye ...

Journal: :The European respiratory journal 2004
J-B Wasserfallen V Erard A Cometta T Calandra O Lamy

Oral levofloxacin is as efficient as sequential antibiotic treatment in community-acquired pneumonia (CAP). The current authors assessed whether oral levofloxacin treatment of patients with severe CAP, followed-up for 30 days, would save money. Over a 12-month period, 129 hospitalised patients with severe non-intensive care unit CAP were randomly assigned to receive either oral levofloxacin or ...

Journal: :Chest 2003
Wing Wai Yew Chi Kuen Chan Chi Chiu Leung Chi Hung Chau Cheuk Ming Tam Poon Chuen Wong Joseph Lee

OBJECTIVE To compare levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis (MDR-TB). PATIENTS AND METHODS A retrospective analysis of 106 patients with MDR-TB (February 1990 through December 2000) receiving directly observed therapy with fluoroquinolone and accompanying drugs, which mainly included aminoglycosides, cycloserine, ethionamide/prothionamide, and pyrazina...

Journal: :Journal of pharmaceutical sciences 2011
Marcelle O Koeppe Rodrigo Cristofoletti Eduardo F Fernandes Silvia Storpirtis Hans E Junginger Sabine Kopp Kamal K Midha Vinod P Shah Salomon Stavchansky Jennifer B Dressman Dirk M Barends

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing levofloxacin as the only active pharmaceutical ingredient (API) are reviewed. According to the current Biopharmaceutics Classification System, levofloxacin can be assigned to Class I. No problems with BE of IR levofloxaci...

Journal: :Revista da Sociedade Brasileira de Medicina Tropical 2015
Reyhan Caliskan Hrisi Bahar Tokman Yusuf Erzin Suat Saribas Pelin Yuksel Bora Kazim Bolek Ecehan Ozge Sevuk Mehmet Demirci Ozge Yılmazli Ozer Akgul Fatma Kalayci Huseyin Cakan Barik Salih Kadir Bal Bekir Kocazeybek

INTRODUCTION Antibiotic resistance is the main factor that affects the efficacy of current therapeutic regimens against Helicobacter pylori. This study aimed to determine the rates of resistance to efficacy clarithromycin, amoxicillin, tetracycline, levofloxacin and metronidazole among H. pylori strains isolated from Turkish patients with dyspepsia. METHODS H. pylori was cultured from corpus ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید